Page last updated: 2024-10-26

doxapram and Recrudescence

doxapram has been researched along with Recrudescence in 2 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research Excerpts

ExcerptRelevanceReference
"An approximate 80% reduction in the frequency of apnea was found with only minimal side effects following low-dose doxapram."7.71Low-dose doxapram therapy for idiopathic apnea of prematurity. ( Fujimura, M; Itahashi, K; Kajiwara, M; Yamazaki, T, 2001)
"An approximate 80% reduction in the frequency of apnea was found with only minimal side effects following low-dose doxapram."3.71Low-dose doxapram therapy for idiopathic apnea of prematurity. ( Fujimura, M; Itahashi, K; Kajiwara, M; Yamazaki, T, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamazaki, T1
Kajiwara, M1
Itahashi, K1
Fujimura, M1
Bairam, A1
Vert, P1

Other Studies

2 other studies available for doxapram and Recrudescence

ArticleYear
Low-dose doxapram therapy for idiopathic apnea of prematurity.
    Pediatrics international : official journal of the Japan Pediatric Society, 2001, Volume: 43, Issue:2

    Topics: Apnea; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Infant, Prem

2001
Low-dose doxapram for apnoea of prematurity.
    Lancet (London, England), 1986, Apr-05, Volume: 1, Issue:8484

    Topics: Apnea; Caffeine; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature, Di

1986